Opus Genetics IRD Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$106.93M-116% | -$49.59M+27.3% | -$68.2M-17.0% | -$58.28M+0.6% | -$58.62M-1.9% | ||
| $53K0.0% | $53K+6.0% | $50K+35.1% | $37K+60.9% | $23K+130% | ||
| $3.95M+16.2% | $3.4M-0.6% | $3.42M+1.2% | $3.38M+2.7% | $3.29M-2.1% | ||
| -$38.99M-10.6% | -$35.25M-7.3% | -$32.86M-3.2% | -$31.83M-10.3% | -$28.85M-12.8% | ||
| —— | $0-100% | $302.5K-50.0% | $605K-33.3% | $907.5K-25.0% | ||
| $0— | $0-100% | $1.21M0.0% | $1.21M0.0% | $1.21M0.0% | ||
| $57.15M+14.3% | $50.02M+93.0% | $25.91M+19.3% | $21.72M-2.8% | $22.36M+424% | ||
| —— | —— | —— | —— | -$5.37M+73.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Opus Genetics generate?
- Opus Genetics (IRD) generated -$39.0M in operating cash flow over the trailing twelve months.
- Where does Opus Genetics's cash flow data come from?
- Every line is extracted from Opus Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
